215 related articles for article (PubMed ID: 32154176)
41. Cell Fusion-Related Proteins and Signaling Pathways, and Their Roles in the Development and Progression of Cancer.
Zhang H; Ma H; Yang X; Fan L; Tian S; Niu R; Yan M; Zheng M; Zhang S
Front Cell Dev Biol; 2021; 9():809668. PubMed ID: 35178400
[TBL] [Abstract][Full Text] [Related]
42. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway.
Yang XC; Wang X; Luo L; Dong DH; Yu QC; Wang XS; Zhao K
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1669-80. PubMed ID: 23832737
[TBL] [Abstract][Full Text] [Related]
43. Linking genomic reorganization to tumor initiation via the giant cell cycle.
Niu N; Zhang J; Zhang N; Mercado-Uribe I; Tao F; Han Z; Pathak S; Multani AS; Kuang J; Yao J; Bast RC; Sood AK; Hung MC; Liu J
Oncogenesis; 2016 Dec; 5(12):e281. PubMed ID: 27991913
[TBL] [Abstract][Full Text] [Related]
44. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
Zhao Y; Zhang T; Wang Q
Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
[TBL] [Abstract][Full Text] [Related]
45. S100A4 in Cancer Metastasis: Wnt Signaling-Driven Interventions for Metastasis Restriction.
Dahlmann M; Kobelt D; Walther W; Mudduluru G; Stein U
Cancers (Basel); 2016 Jun; 8(6):. PubMed ID: 27331819
[TBL] [Abstract][Full Text] [Related]
46. Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH.
Gründker C; Bauerschmitz G; Schubert A; Emons G
Int J Oncol; 2016 Jun; 48(6):2713-21. PubMed ID: 27098123
[TBL] [Abstract][Full Text] [Related]
47. S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma.
Zou M; Al-Baradie RS; Al-Hindi H; Farid NR; Shi Y
Br J Cancer; 2005 Nov; 93(11):1277-84. PubMed ID: 16265347
[TBL] [Abstract][Full Text] [Related]
48. Restoration of S100A4 expression enhances invasive and metastatic potentials of COLO16 cutaneous squamous cancer cells.
Yu LJ; Li Y; Li C; Li H; Wu ML; Liu ZL; Kong QY; Chen XY; Liu XY; An LJ; Liu J
Cancer Biomark; 2014; 14(5):325-33. PubMed ID: 25171474
[TBL] [Abstract][Full Text] [Related]
49. MALAT1 promotes colorectal cancer cell proliferation/migration/invasion via PRKA kinase anchor protein 9.
Yang MH; Hu ZY; Xu C; Xie LY; Wang XY; Chen SY; Li ZG
Biochim Biophys Acta; 2015 Jan; 1852(1):166-74. PubMed ID: 25446987
[TBL] [Abstract][Full Text] [Related]
50. Polyploid giant cancer cells, cytokines and cytomegalovirus in breast cancer progression.
Haidar Ahmad S; El Baba R; Herbein G
Cancer Cell Int; 2023 Jun; 23(1):119. PubMed ID: 37340387
[TBL] [Abstract][Full Text] [Related]
51. S100A4-MYH9 Axis Promote Migration and Invasion of Gastric Cancer Cells by Inducing TGF-β-Mediated Epithelial-Mesenchymal Transition.
Li F; Shi J; Xu Z; Yao X; Mou T; Yu J; Liu H; Li G
J Cancer; 2018; 9(21):3839-3849. PubMed ID: 30410586
[TBL] [Abstract][Full Text] [Related]
52. Estrogen‑related receptor γ promotes the migration and metastasis of endometrial cancer cells by targeting S100A4.
Hua T; Wang X; Chi S; Liu Y; Feng D; Zhao Y; Wang H
Oncol Rep; 2018 Aug; 40(2):823-832. PubMed ID: 29901152
[TBL] [Abstract][Full Text] [Related]
53. RLN2 regulates in vitro invasion and viability of osteosarcoma MG-63 cells via S100A4/MMP-9 signal.
Ren XF; Zhao H; Gong XC; Wang LN; Ma JF
Eur Rev Med Pharmacol Sci; 2015; 19(6):1030-6. PubMed ID: 25855929
[TBL] [Abstract][Full Text] [Related]
54.
Peerapen P; Sueksakit K; Boonmark W; Yoodee S; Thongboonkerd V
J Cancer; 2022; 13(2):373-384. PubMed ID: 35069887
[TBL] [Abstract][Full Text] [Related]
55. Increased expressions of SATB1 and S100A4 are associated with poor prognosis in human colorectal carcinoma.
Niu Y; Wang L; Cheng C; Du C; Lu X; Wang G; Liu J
APMIS; 2015 Feb; 123(2):93-101. PubMed ID: 25257341
[TBL] [Abstract][Full Text] [Related]
56. Epigenetic silencing of miR-520c leads to induced S100A4 expression and its mediated colorectal cancer progression.
Mudduluru G; Ilm K; Fuchs S; Stein U
Oncotarget; 2017 Mar; 8(13):21081-21094. PubMed ID: 28423501
[TBL] [Abstract][Full Text] [Related]
57. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
[TBL] [Abstract][Full Text] [Related]
58. S100A4 siRNA inhibits human pancreatic cancer cell invasion in vitro.
Li N; Song MM; Chen XH; Liu LH; Li FS
Biomed Environ Sci; 2012 Aug; 25(4):465-70. PubMed ID: 23026527
[TBL] [Abstract][Full Text] [Related]
59. S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway.
Zhang K; Zhang M; Zhao H; Yan B; Zhang D; Liang J
Dis Esophagus; 2012; 25(8):731-9. PubMed ID: 22458600
[TBL] [Abstract][Full Text] [Related]
60. S100A4 promotes endometrial cancer progress through epithelial-mesenchymal transition regulation.
Hua T; Liu S; Xin X; Cai L; Shi R; Chi S; Feng D; Wang H
Oncol Rep; 2016 Jun; 35(6):3419-26. PubMed ID: 27109209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
